Search
Confirm
Cancel
News

News

Fusen Pharmaceutical Stock code:1652.HK
Location:
Homepage
-
-
-
Zhang Boli: The availability of Chinese medicine is most worthy of recognition in the war against the "epidemic"

Zhang Boli: The availability of Chinese medicine is most worthy of recognition in the war against the "epidemic"

  • Categories:Media Information
  • Author:Chen Mengyi
  • Origin:China News Service
  • Time of issue:2021-10-18
  • Views:

(Summary description)Nanning, October 16 (Lin Jieqi) Academician of the Chinese Academy of Engineering and Honorary President of Tianjin University of Traditional Chinese Medicine Zhang Boli stated in Nanning on the 16th that “in the fight against the new crown pneumonia epidemic, the accessibility of traditional Chinese medicine is most worthy of recognition. Under the circumstances, Chinese medicine fights for the vitality of patients and the nation." On the same day, the 2021 academic annual meeting of the Cardiovascular Branch of the Chinese Society of Chinese Medicine was held in Nanning, Guangxi, and Zhang Boli delivered a speech at the meeting. He said that at present, the epidemic situation in various parts of China is still spreading in many places. During the period, the use of traditional Chinese medicine treatment methods has achieved good results in the repeated anti-epidemic tests. Zhang Boli said that the new crown pneumonia epidemic is still in a pandemic. The good news is that in the past more than a month, the epidemic has slowed down globally. The domestic epidemic situation is dynamically cleared, but judging from the outbreaks in Jiangsu, Fujian, Heilongjiang, Inner Mongolia and other places, multiple outbreaks have occurred from time to time. He said that China still needs to tighten the string of epidemic prevention and do a good job of "preventing foreign imports and internal defenses against rebound" and cannot be taken lightly. Zhang Boli said that after TCM syndrome analysis, it is determined that the new coronary pneumonia is a "damp virus disease." Zhang Boli recalled his anti-epidemic experience in Wuhan and said that Chinese medicine emphasizes "dialectical treatment", but Wuhan is a special situation. Faced with thousands of patients, it is impossible to dialectical evidence one by one, and can only adopt similar symptoms caused by the same virus. , Use traditional Chinese medicine to treat. At the same time, the establishment of a system of intervention, the formation of traditional Chinese medicine wards, and the use of integrated traditional Chinese and Western medicine for treatment. Under the emergency situation of the Wuhan epidemic at that time, Zhang Boli and his team could only "build roads with old medicines" and screened nearly 60 kinds of Chinese medicines within 10 days, all of which have a certain inhibitory effect on new coronary pneumonia. At the same time, Jinhua Qinggan Granules, Lianhua Qingwen Capsules, Xuebijing Injection, Qingfei Paidu Recipe, Xuanfei Baidu Recipe, and Huashibaidu Recipe were developed with outstanding effects. "Traditional Chinese medicine has thousands of years of anti-epidemic history. It has summarized a wealth of clinical experience. It is indeed effective and convenient." Zhang Boli said. Traditional Chinese medicine decoctions such as "Maxing Shigan Decoction" and "Maxing Ligan Decoction" are also anti-epidemic. It was widely used during the period. Zhang Boli said that Chinese medicine has played an important role in fighting the epidemic and has also promoted its own development. In order to promote the inheritance and innovation of traditional Chinese medicine, relevant national ministries and commissions have issued plans to focus on supporting the National Traditional Chinese Medicine Center, Regional Traditional Chinese Medicine Medical Centers, National Traditional Chinese Medicine Inheritance Innovation Center, National Traditional Chinese Medicine Epidemic Prevention and Control Base, "flagship" hospitals of collaboration between Chinese and Western medicine, and key hospitals with Chinese medicine characteristics With the construction of the famous doctor hall, Chinese medicine has ushered in new development opportunities. In order to promote the development of traditional Chinese medicine in the post-epidemic era, Zhang Boli stated that it is necessary to create new evidence-based evaluation methods that meet the characteristics of traditional Chinese medicine based on the concept of evidence-based medicine, strengthen the training of integrated Chinese and Western talents, and jointly build and share alliances through Chinese herbal medicine bases to promote standardized cultivation of Chinese medicine , To promote the high-quality development of Chinese medicine.

Zhang Boli: The availability of Chinese medicine is most worthy of recognition in the war against the "epidemic"

(Summary description)Nanning, October 16 (Lin Jieqi) Academician of the Chinese Academy of Engineering and Honorary President of Tianjin University of Traditional Chinese Medicine Zhang Boli stated in Nanning on the 16th that “in the fight against the new crown pneumonia epidemic, the accessibility of traditional Chinese medicine is most worthy of recognition. Under the circumstances, Chinese medicine fights for the vitality of patients and the nation."

On the same day, the 2021 academic annual meeting of the Cardiovascular Branch of the Chinese Society of Chinese Medicine was held in Nanning, Guangxi, and Zhang Boli delivered a speech at the meeting. He said that at present, the epidemic situation in various parts of China is still spreading in many places. During the period, the use of traditional Chinese medicine treatment methods has achieved good results in the repeated anti-epidemic tests.

Zhang Boli said that the new crown pneumonia epidemic is still in a pandemic. The good news is that in the past more than a month, the epidemic has slowed down globally. The domestic epidemic situation is dynamically cleared, but judging from the outbreaks in Jiangsu, Fujian, Heilongjiang, Inner Mongolia and other places, multiple outbreaks have occurred from time to time. He said that China still needs to tighten the string of epidemic prevention and do a good job of "preventing foreign imports and internal defenses against rebound" and cannot be taken lightly.

Zhang Boli said that after TCM syndrome analysis, it is determined that the new coronary pneumonia is a "damp virus disease."

Zhang Boli recalled his anti-epidemic experience in Wuhan and said that Chinese medicine emphasizes "dialectical treatment", but Wuhan is a special situation. Faced with thousands of patients, it is impossible to dialectical evidence one by one, and can only adopt similar symptoms caused by the same virus. , Use traditional Chinese medicine to treat. At the same time, the establishment of a system of intervention, the formation of traditional Chinese medicine wards, and the use of integrated traditional Chinese and Western medicine for treatment.

Under the emergency situation of the Wuhan epidemic at that time, Zhang Boli and his team could only "build roads with old medicines" and screened nearly 60 kinds of Chinese medicines within 10 days, all of which have a certain inhibitory effect on new coronary pneumonia. At the same time, Jinhua Qinggan Granules, Lianhua Qingwen Capsules, Xuebijing Injection, Qingfei Paidu Recipe, Xuanfei Baidu Recipe, and Huashibaidu Recipe were developed with outstanding effects.

"Traditional Chinese medicine has thousands of years of anti-epidemic history. It has summarized a wealth of clinical experience. It is indeed effective and convenient." Zhang Boli said. Traditional Chinese medicine decoctions such as "Maxing Shigan Decoction" and "Maxing Ligan Decoction" are also anti-epidemic. It was widely used during the period.

Zhang Boli said that Chinese medicine has played an important role in fighting the epidemic and has also promoted its own development. In order to promote the inheritance and innovation of traditional Chinese medicine, relevant national ministries and commissions have issued plans to focus on supporting the National Traditional Chinese Medicine Center, Regional Traditional Chinese Medicine Medical Centers, National Traditional Chinese Medicine Inheritance Innovation Center, National Traditional Chinese Medicine Epidemic Prevention and Control Base, "flagship" hospitals of collaboration between Chinese and Western medicine, and key hospitals with Chinese medicine characteristics With the construction of the famous doctor hall, Chinese medicine has ushered in new development opportunities.

In order to promote the development of traditional Chinese medicine in the post-epidemic era, Zhang Boli stated that it is necessary to create new evidence-based evaluation methods that meet the characteristics of traditional Chinese medicine based on the concept of evidence-based medicine, strengthen the training of integrated Chinese and Western talents, and jointly build and share alliances through Chinese herbal medicine bases to promote standardized cultivation of Chinese medicine , To promote the high-quality development of Chinese medicine.

  • Categories:Media Information
  • Author:Chen Mengyi
  • Origin:China News Service
  • Time of issue:2021-10-18 09:35
  • Views:
Information

Nanning, October 16 (Lin Jieqi) Academician of the Chinese Academy of Engineering and Honorary President of Tianjin University of Traditional Chinese Medicine Zhang Boli stated in Nanning on the 16th that “in the fight against the new crown pneumonia epidemic, the accessibility of traditional Chinese medicine is most worthy of recognition. Under the circumstances, Chinese medicine fights for the vitality of patients and the nation."

On the same day, the 2021 academic annual meeting of the Cardiovascular Branch of the Chinese Society of Chinese Medicine was held in Nanning, Guangxi, and Zhang Boli delivered a speech at the meeting. He said that at present, the epidemic situation in various parts of China is still spreading in many places. During the period, the use of traditional Chinese medicine treatment methods has achieved good results in the repeated anti-epidemic tests.

Zhang Boli said that the new crown pneumonia epidemic is still in a pandemic. The good news is that in the past more than a month, the epidemic has slowed down globally. The domestic epidemic situation is dynamically cleared, but judging from the outbreaks in Jiangsu, Fujian, Heilongjiang, Inner Mongolia and other places, multiple outbreaks have occurred from time to time. He said that China still needs to tighten the string of epidemic prevention and do a good job of "preventing foreign imports and internal defenses against rebound" and cannot be taken lightly.

Zhang Boli said that after TCM syndrome analysis, it is determined that the new coronary pneumonia is a "damp virus disease."

Zhang Boli recalled his anti-epidemic experience in Wuhan and said that Chinese medicine emphasizes "dialectical treatment", but Wuhan is a special situation. Faced with thousands of patients, it is impossible to dialectical evidence one by one, and can only adopt similar symptoms caused by the same virus. , Use traditional Chinese medicine to treat. At the same time, the establishment of a system of intervention, the formation of traditional Chinese medicine wards, and the use of integrated traditional Chinese and Western medicine for treatment.

Under the emergency situation of the Wuhan epidemic at that time, Zhang Boli and his team could only "build roads with old medicines" and screened nearly 60 kinds of Chinese medicines within 10 days, all of which have a certain inhibitory effect on new coronary pneumonia. At the same time, Jinhua Qinggan Granules, Lianhua Qingwen Capsules, Xuebijing Injection, Qingfei Paidu Recipe, Xuanfei Baidu Recipe, and Huashibaidu Recipe were developed with outstanding effects.

"Traditional Chinese medicine has thousands of years of anti-epidemic history. It has summarized a wealth of clinical experience. It is indeed effective and convenient." Zhang Boli said. Traditional Chinese medicine decoctions such as "Maxing Shigan Decoction" and "Maxing Ligan Decoction" are also anti-epidemic. It was widely used during the period.

Zhang Boli said that Chinese medicine has played an important role in fighting the epidemic and has also promoted its own development. In order to promote the inheritance and innovation of traditional Chinese medicine, relevant national ministries and commissions have issued plans to focus on supporting the National Traditional Chinese Medicine Center, Regional Traditional Chinese Medicine Medical Centers, National Traditional Chinese Medicine Inheritance Innovation Center, National Traditional Chinese Medicine Epidemic Prevention and Control Base, "flagship" hospitals of collaboration between Chinese and Western medicine, and key hospitals with Chinese medicine characteristics With the construction of the famous doctor hall, Chinese medicine has ushered in new development opportunities.

In order to promote the development of traditional Chinese medicine in the post-epidemic era, Zhang Boli stated that it is necessary to create new evidence-based evaluation methods that meet the characteristics of traditional Chinese medicine based on the concept of evidence-based medicine, strengthen the training of integrated Chinese and Western talents, and jointly build and share alliances through Chinese herbal medicine bases to promote standardized cultivation of Chinese medicine , To promote the high-quality development of Chinese medicine.

Related News

Fusen

Fusen pharmaceutical: metformin hydrochloride sustained release tablets passed the consistency evaluation

Fusen pharmaceutical metformin hydrochloride sustained-release tablets have successfully passed the evaluation of the consistency of quality and efficacy of generic drugs! Metformin Hydrochloride Sustained Release Tablets, a diabetes drug, has been approved by the State Administration for drug control. This product has successfully passed the quality and efficacy consistency evaluation of generic drugs, which is an authoritative recognition of the R & D capacity, production and quality management system and clinical efficacy of Fusen pharmaceutical, further highlights the product brand of Fusen pharmaceutical, helps to improve the market competitiveness of the drug, and accumulates valuable experience for the company's follow-up products to carry out generic drug consistency evaluation. ▲ notice of approval from the State Drug Administration Metformin Hydrochloride Tablets is the basic medicine for diabetes. It is used for diet and physical exercise to control type 2 diabetes patients with blood glucose inefficacy, especially obesity and hyperinsulinemia. As a first-line drug for the treatment of type II diabetes, metformin is often used in combination with other oral hypoglycemic agents. ▲ for medical professionals only Because of the superiority of metformin, it is listed as the first-line treatment for hypoglycemic treatment in the guidelines for prevention and treatment of type II diabetes, formulated by professional academic organizations both at home and abroad. As the holder of drug marketing license, Fusen pharmaceutical will not forget its original intention, forge ahead, strictly control the product quality, and constantly optimize the product layout, so that more drugs of Fusen pharmaceutical can benefit the majority of patients.
2022-04-26
Jiaheng

Jiaheng pharmaceutical was approved to set up a post doctoral research workstation sub station

Recently, the Department of human resources and social security of Guangdong Province issued a notice that the National Postdoctoral Management Committee approved Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of Fusen pharmaceutical, to set up a postdoctoral scientific research workstation branch. ▲ exhibition hall of Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd ▲ exhibition hall of Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Co., Ltd. is a research and development subsidiary established by Fusen pharmaceutical in response to the national development strategy of traditional Chinese medicine. In order to enhance the independent research and development ability of traditional Chinese medicine, take the research and development of high-quality and effective traditional Chinese medicine as the main goal, and integrate the high-quality traditional Chinese medicine resources in the industry. ▲ Guangdong Macao science and Technology Industrial Park of traditional Chinese Medicine The company is located in Hengqin Guangdong Macao cooperative traditional Chinese medicine science and Technology Industrial Park. It is the first R & D platform settled in the industrial park and officially operated after the establishment of Hengqin Guangdong Macao deep cooperation zone. It is the supporting unit of the large variety cultivation sub center of traditional Chinese medicine of the national traditional Chinese medicine modernization engineering technology center. Its main business is the R & D of innovative traditional Chinese medicine and secondary development of traditional Chinese medicine, chemical medicine raw materials and preparations, light medicine and beauty products and great health products. This time, Jiaheng pharmaceutical was approved to set up a post doctoral research workstation sub station, which is an affirmation of Jiaheng pharmaceutical's technological innovation ability and R & D ability, creates conditions for the company's talent training and the improvement of technological innovation ability, is conducive to further promoting the company's cooperation with universities and scientific research institutes, is conducive to the introduction of high-end R & D talents, is conducive to further improving the company's independent R & D ability and realizing the landing and transformation of scientific research achievements, Promote the sustainable innovation and development of the company and continuously improve the core competitiveness of the company.
2022-04-19

WeChat

福森药业

Copyright © 2021 Fusen Pharmaceutical Company Limited

豫ICP备2021028871号  Powered by www.300.cn

Copyright © 2021 Fusen Pharmaceutical  All Rights Reserved.      豫ICP备2021028871号        Powered by www.300.cn